BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1355 related articles for article (PubMed ID: 23140924)

  • 21. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
    Linder R; Fuhrmann J; Hammerschmidt D
    Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term prognosis of medullary thyroid carcinoma in 39 patients.
    Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
    Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
    Mirallié E; Iacobone M; Sebag F; Henry JF
    Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioactive iodine treatment in medullary thyroid carcinoma.
    Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
    Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Medullary carcinoma of the thyroid].
    Francomano F; Cotellese R; Scipione P; Ricci A; D'Aulerio A; Ricciardi A; Orlandi N; Napolitano L
    G Chir; 1996 Oct; 17(10):535-42. PubMed ID: 9044606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micromedullary thyroid cancer: how micro is truly micro?
    Pillarisetty VG; Katz SC; Ghossein RA; Tuttle RM; Shaha AR
    Ann Surg Oncol; 2009 Oct; 16(10):2875-81. PubMed ID: 19568813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medullary thyroid carcinoma (MTC)--clinical and molecular aspects on the basis of own experience.
    Pomorski L; Bartkowiak J; Pisarek H; Bartos M; Narebski J
    Neoplasma; 2000; 47(5):323-6. PubMed ID: 11130252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
    Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neck management in medullary thyroid carcinoma.
    Oskam IM; Hoebers F; Balm AJ; van Coevorden F; Bais EM; Hart AM; van den Brekel MW
    Eur J Surg Oncol; 2008 Jan; 34(1):71-6. PubMed ID: 17555910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
    Cupisti K; Wolf A; Raffel A; Schott M; Miersch D; Yang Q; Eisenberger CF; Röher HD; Knoefel WT
    Ann Surg; 2007 Nov; 246(5):815-21. PubMed ID: 17968174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review analysis of medullary carcinoma thyroid--15-year Indian experience.
    Dorairajan N; Saravanakumar P; Karthikeyan S; Siddharth D; Kanna S
    J Indian Med Assoc; 2005 Aug; 103(8):415-7, 427. PubMed ID: 16363195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Decision making in postoperative incidentally found small C-cell-carcinoma].
    Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT
    Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Micromedullary thyroid carcinoma: school experience].
    Palermo S; Di Matteo FM; Savino G; Di Marco C; Catania A; De Antoni E
    G Chir; 2010; 31(6-7):299-302. PubMed ID: 20646376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of nodal metastasis for primary and reoperative thyroid cancer.
    Machens A; Hinze R; Thomusch O; Dralle H
    World J Surg; 2002 Jan; 26(1):22-8. PubMed ID: 11898029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skip metastases in thyroid cancer leaping the central lymph node compartment.
    Machens A; Holzhausen HJ; Dralle H
    Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.